Department of Chemistry and the Oxford Centre for Integrative Systems Biology, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, United Kingdom.
Org Biomol Chem. 2011 Jan 7;9(1):127-35. doi: 10.1039/c0ob00592d. Epub 2010 Nov 15.
Based on structural analysis of the human 2-oxoglutarate (2OG) dependent JMJD2 histone N(ε)-methyl lysyl demethylase family, 3-substituted pyridine 2,4-dicarboxylic acids were identified as potential inhibitors with possible selectivity over other human 2OG oxygenases. Microwave-assisted palladium-catalysed cross coupling methodology was developed to install a diverse set of substituents on the sterically demanding C-3 position of a pyridine 2,4-dicarboxylate scaffold. The subsequently prepared di-acids were tested for in vitro inhibition of the histone demethylase JMJD2E and another human 2OG oxygenase, prolyl-hydroxylase domain isoform 2 (PHD2, EGLN1). A subset of substitution patterns yielded inhibitors with selectivity for JMJD2E over PHD2, demonstrating that structure-based inhibitor design can enable selective inhibition of histone demethylases over related human 2OG oxygenases.
基于对依赖 2-氧戊二酸(2OG)的人 JMJD2 组蛋白 N(ε)-甲基赖氨酸脱甲基酶家族的结构分析,鉴定出 3-取代吡啶 2,4-二羧酸可能是潜在的抑制剂,对其他人类 2OG 加氧酶可能具有选择性。开发了微波辅助钯催化交叉偶联方法,以在吡啶 2,4-二羧酸酯支架的空间位阻较大的 C-3 位置上引入多种取代基。随后制备的二羧酸被测试体外抑制组蛋白去甲基酶 JMJD2E 和另一种人类 2OG 加氧酶脯氨酰-羟化酶结构域同种型 2(PHD2,EGLN1)的活性。一组取代模式产生了对 JMJD2E 具有选择性的抑制剂,而对 PHD2 没有抑制作用,这表明基于结构的抑制剂设计可以实现对组蛋白去甲基酶的选择性抑制,而不抑制相关的人类 2OG 加氧酶。